All financings
COMPANY TRANSACTIONS

Glucotrack, Inc.

GCTKNasdaqMedical - Devices

Deal details

1 transaction in the database

TRANSACTION REPORT · SEC DISCLOSURES

Deal notes

Not yet verifiedClosing confirmation

Closing has not been confirmed in the reviewed sources. This record does not establish that funding was received.

Gross proceeds$3.1M
Offering price$2.04
Discount to prior close-0.5%
Warrant coverage—
Placement agent / underwriterDawson James Securities, Inc.

Transaction overview

01

Glucotrack, Inc. announced a $3.1M best-efforts public offering at $2.04 per share. Dawson James Securities, Inc. acted as placement agent for the financing.

Financing type
Best-Efforts Public Offering
Announcement date
Sep 24, 2026
Pricing date
Sep 24, 2026
Closing date
—
Filing date
Sep 24, 2026
Status
Priced
Market cap before announcement
$451,053.82
Prior closing price
$2.03
Raise as % of market cap
687.3%

Market data · FMP

Historical market cap
$451,053.82
Market date
Sep 23, 2026
Closing price
$2.03
Latest reported shares outstanding
798,143
Latest reported float shares
641,159
Share-data date
Sep 29, 2026

Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Sep 30, 2026.

Financial Modeling Prep ↗

Financing terms

02

Equity

Common shares issued
169,388
Price per share
$2.04
Pre-funded warrants
1,350,220
Pre-financing shares disclosed in filing
—
Shares outstanding after financing
—

Fees & transaction economics

03
Placement agent / underwriting fee
8%
Agent fee amount
$248,000
Management fee
—
Other offering expenses (estimated)
—
Net proceeds (estimated)
—
Net proceeds as % of gross
—

Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.

Transaction participants

04
Investor names: —

Source documents

05

SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.

EX-10.1 · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗
EX-10.2 · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗
EX-10.3 · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗
EX-4.1 · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗
EX-5.1 · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗
EX-99.1 · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗
8-K · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗
424B5 · Glucotrack, Inc.SEC filing · Sep 24, 2026
Open source ↗
FMP historical market data · GCTKMarket data · Sep 23, 2026
Open source ↗
SEC deal terms · FMP market data where available · Initial research sample, not complete market coverage. AI-assisted source review; original evidence is available in each report. Names and tickers reflect the transaction date. A dash (—) means the value is unavailable.